SavedAdd your journal

Journals / Anatolian Current Medical Journal / 2025 / Volume: 7 Issue: 6

Prognostic factors in intensive care unit patients with ventilator associated pneumonia: the role of comorbidity and clinical severity scores

Vücut kitle indeksi ve komorbiditelerin yoğun bakım ünitesinde nozokomiyal pnömoni olan hastaların prognozuna etkisi

Ülkü Arslan(AKDENIZ UNIVERSITY)0000-0001-5277-9034
Aysun Alcı(Kahramanmaras necip fazıl city hospital)0000-0002-7912-7375
Melike Cengiz(AKDENIZ UNIVERSITY)0000-0001-6417-6214
Murat Yılmaz(AKDENIZ UNIVERSITY)0000-0002-7288-1981
Pages
—
Publication Date
2025-10-26
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall ICU mortality in VAP patients was 64%, and the 28-day ICU mortality was 55%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The objective of this study is to ascertain patient and other related characteristics, such as body-mass index (BMI) and comorbidities, that may be associated with prognosis in patients with ventilator-associated pneumonia (VAP) in the Anaesthesia Intensive Care Units (ICU) of Akdeniz University.
📊
Key Findings & Data:Results: The study comprised of 111 patients diagnosed with VAP.
💡
Conclusion & Impact:The overall ICU mortality in VAP patients was 64%, and the 28-day ICU mortality was 55%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Intensive care unit · mortality · ventilator associated pneumonia

Abstract

Aims: The objective of this study is to ascertain patient and other related characteristics, such as body-mass index (BMI) and comorbidities, that may be associated with prognosis in patients with ventilator-associated pneumonia (VAP) in the Anaesthesia Intensive Care Units (ICU) of Akdeniz University. Methods: It was designed as a retrospective cohort study in which patients with a diagnosis of VAP in the ICU was included. The demographic and clinical data obtained and analysed were age, gender, comorbidities, BMI, Charlson Comorbidity Index (CCI) and the reason for admission to the ICU. The clinical severity of patients was determined by the Acute Physiology and Chronic Health Evaluation-II (APACHE II) score and the Sequential Organ Failure Assessment (SOFA) score. Results: The study comprised of 111 patients diagnosed with VAP. The overall ICU mortality in VAP patients was 64%, and the 28-day ICU mortality was 55%. A number of factors have been identified as being independently associated with mortality in the studied cohort. These factors include increasing age, SOFA score on the day of VAP and the presence of chronic corticosteroid use. Conclusion: VAP remains a significant problem in ICUs, and mortality is a major issue in these patients. The implementation of more effective control measures is of great importance. Among all the variables studied, age and SOFA score demonstrated the most consistent and statistically significant discriminatory power.

Özet

Amaç: Bu çalışmanın amacı, Akdeniz Üniversitesi Anestezi Yoğun Bakım Ünitelerinde (YBÜ) ventilatör ilişkili pnömoni (VAP) hastalarında prognoz ile ilişkili olabilecek hasta ve diğer ilgili özellikleri, örneğin vücut kitle indeksi (VKİ) ve komorbiditeleri belirlemektir. Yöntemler: Bu çalışma, yoğun bakım ünitesinde VAP tanısı alan hastaları içeren retrospektif bir kohort çalışması olarak tasarlanmıştır. Elde edilen ve analiz edilen demografik ve klinik veriler yaş, cinsiyet, komorbiditeler, BMI, Charlson komorbidite indeksi (CCI) ve yoğun bakım ünitesine yatış nedeniydi. Hastaların klinik ciddiyeti Akut Fizyoloji ve Kronik Sağlık Değerlendirmesi-II (APACHE II) skoru ve Sıralı Organ Yetmezliği Değerlendirmesi (SOFA) skoru ile belirlendi. Sonuçlar: Çalışma, VAP tanısı alan 111 hastayı kapsamaktadır. VAP hastalarında genel yoğun bakım ünitesi mortalitesi %64, 28 günlük yoğun bakım ünitesi mortalitesi ise %55 olarak saptanmıştır. Çalışmada, mortalite ile bağımsız olarak ilişkili olduğu belirlenen bir dizi faktör saptanmıştır. Bu faktörler arasında yaşın artması, yüksek CCI, APACHE II, SOFA skorları, diabetes mellitus, solid organ malignitesi ve immünosupresyonun varlığı (kronik kortikosteroid kullanımı ve immünosupresif tedavi) yer almaktadır. Sonuç: VAP, yoğun bakım ünitelerinde önemli bir sorun olmaya devam etmekte ve bu hastalarda mortalite önemli bir sorun teşkil etmektedir. Daha etkili kontrol önlemlerinin uygulanması büyük önem taşımaktadır. Tek bir parametre seti yerine kombine bir modelin kullanılması, bu hastalarda mortalitenin daha kesin bir şekilde tahmin edilmesini kolaylaştırabilir.

🔖

Cite This Article

Arslan, Ü., Alcı, A., Cengiz, M., Yılmaz, M. (2025). Prognostic factors in intensive care unit patients with ventilator associated pneumonia: the role of comorbidity and clinical severity scores. Anatolian Current Medical Journal, Volume: 7 Issue: 6. https://doi.org/10.38053/acmj.1768219

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (56)

  1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903. doi:10.1164/ajrccm.165.7.2105078
  2. Vincent JL, de Souza Barros D, Cianferoni S. Diagnosis, management and prevention of ventilator-associated pneumonia: an update. Drugs. 2010;70(15):1927-1944. doi:10.2165/11538080-000000000-00000
  3. Feng DY, Zhou YQ, Zhou M, Zou XL, Wang YH, Zhang TT. Risk factors for mortality due to ventilator-associated pneumonia in a Chinese hospital: a retrospective study. Med Sci Monit. 2019;25:7660-7665. doi: 10.12659/MSM.916356
  4. Huang Y, Jiao Y, Zhang J, et al. Microbial etiology and prognostic factors of ventilator-associated pneumonia: a multicenter retrospective study in Shanghai. Clin Infect Dis. 2018;67(suppl_2):S146-S152. doi:10.1093/cid/ciy686
  5. Ding C, Zhang Y, Yang Z, et al. Incidence, temporal trend and factors associated with ventilator-associated pneumonia in mainland China: a systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):468. doi:10.1186/s12879-017-2566-7
  6. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111. doi: 10.1093/cid/ciw353
  7. Hespanhol V, Bárbara C. Pneumonia mortality, comorbidities matter? Pulmonology. 2020;26(3):123-129. doi:10.1016/j.pulmoe.2019.10.003
  8. Vo-Pham-Minh T, Duong-Thi-Thanh V, Nguyen T, et al. The impact of risk factors on treatment outcomes of nosocomial pneumonia due to gram-negative bacteria in the intensive care unit. Pulm Ther. 2021;7(2): 563-574. doi:10.1007/s41030-021-00175-4
  9. Hamidi AA, Kescioglu S. Identification of factors affecting mortality in late-onset ventilator-associated pneumonia. Eurasian J Med. 2020;52(3): 254-258. doi:10.5152/eurasianjmed.2020.20005
  10. Kwa AL, Low JG, Lee E, Kurup A, Chee HL, Tam VH. The impact of multidrug resistance on the outcomes of critically ill patients with gram-negative bacterial pneumonia. Diagn Microbiol Infect Dis. 2007;58(1): 99-104. doi:10.1016/j.diagmicrobio.2006.11.014
  11. Pierce VM, Bhowmick T, Simner PJ. Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023. J Clin Microbiol. 2023;61(11): e0007422. doi:10.1128/jcm.00074-22
  12. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
  13. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-2533. doi:10.1001/jama.2012.5669
  14. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204. doi:10.1186/cc11454
  15. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145(1): 24-33. doi:10.1111/j.1365-2141.2009.07600.x
  16. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network report, data summary for 2011, device-associated module. Am J Infect Control. 2013;41(4):286-300. doi:10.1016/j.ajic.2013.01.002
  17. Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2017;36(11):1999-2006. doi:10.1007/s10096-016-2703-z
  18. Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020;46(5):888-906. doi: 10.1007/s00134-020-05980-0
  19. Stoclin A, Rotolo F, Hicheri Y, et al. Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients.Support Care Cancer. 2020;28(1):193-200. doi:10.1007/s00520-019-04800-6
  20. Forel JM, Voillet F, Pulina D, et al. Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Crit Care. 2012;16(2):R65. doi:10.1186/cc11312
  21. Ucgun I, Dagli CE, Kiremitci A, Yildirim H, Ak G, Aslan S. Effects of isolation rooms on the prevalence of hospital acquired pneumonia in a respiratory ICU. Eur Rev Med Pharmacol Sci. 2013;17(Suppl 1):2-8.
  22. Leblebicioglu H, Yalcin AN, Rosenthal VD, et al. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 11 adult intensive care units from 10 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Infection. 2013;41(2):447-456. doi:10.1007/s15010-013-0407-1
  23. Belay CM, Zewale TA, Amlak BT, Abebe TG, Hailu G. Incidence and predictors of ventilator-associated pneumonia among adult intubated patients in Bahir Dar Specialized Hospitals, 2021: a retrospective follow-up study. Int J Gen Med. 2022;15:8173-8182. doi:10.2147/IJGM.S380301
  24. Karatas M, Saylan S, Kostakoglu U, Yilmaz G. An assessment of ventilator-associated pneumonias and risk factors identified in the intensive care unit. Pak J Med Sci. 2016;32(4):817-822. doi:10.12669/pjms.324.10381
  25. Giard M, Lepape A, Allaouchiche B, et al. Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors. J Crit Care. 2008;23(1):27-33. doi:10.1016/j.jcrc.2007.08.005
  26. Magill SS, Li Q, Gross C, Dudeck M, Allen-Bridson K, Edwards JR. Incidence and characteristics of ventilator-associated events reported to the National Healthcare Safety Network in 2014. Crit Care Med. 2016; 44(12):2154-2162. doi:10.1097/CCM.0000000000001871
  27. Sharpe JP, Magnotti LJ, Weinberg JA, et al. Gender disparity in ventilator-associated pneumonia following trauma: identifying risk factors for mortality. J Trauma Acute Care Surg. 2014;77(1):161-165. doi: 10.1097/TA.0000000000000251
  28. Mumtaz H, Saqib M, Khan W, et al. Ventilator associated pneumonia in intensive care unit patients: a systematic review. Ann Med Surg (Lond). 2023;85(6):2932-2939. doi:10.1097/MS9.0000000000000836
  29. Zhao X, Wang L, Wei N, et al. Epidemiological and clinical characteristics of healthcare-associated infection in elderly patients in a large Chinese tertiary hospital: a 3-year surveillance study. BMC Infect Dis. 2020;20(1):121. doi:10.1186/s12879-020-4840-3
  30. Decelle L, Thys F, Zech F, Verschuren F. Ventilation-associated pneumonia after intubation in the prehospital or the emergency unit. Eur J Emerg Med. 2013;20(1):61-63. doi:10.1097/MEJ.0b013e3283501677
  31. Chastre J. Conference summary: ventilator-associated pneumonia.Respir Care. 2005;50(7):975-983.
  32. But A, Yetkin MA, Kanyilmaz D, et al. Analysis of epidemiology and risk factors for mortality in ventilator-associated pneumonia attacks in intensive care unit patients. Turk J Med Sci. 2017;47(3):812-816. doi:10. 3906/sag-1601-38
  33. Yesilbag Z, Seker YT. Epidemiology and the risk factors for mortality in ventilator-associated pneumonia. Med J Bakirkoy. 2020;16(3):309. doi: 10.5222/BMJ.2020.43760
  34. Gvozdenović L, Kolarović J, Sarkanović-Lukić M, Popović M, Trivić S. Incidence and outcome of ventilator-associated pneumonia (our experience). Braz J Infect Dis. 2012;16(6):599-600. doi:10.1016/j.bjid. 2012.07.012
  35. Agrafiotis M, Siempos II, Ntaidou TK, Falagas ME. Attributable mortality of ventilator-associated pneumonia: a meta-analysis. Int J Tuberc Lung Dis. 2011;15(9):1154-v. doi:10.5588/ijtld.10.0498
  36. Semet C. The ongoing challenge of ventilator-associated pneumonia: epidemiology, prevention, and risk factors for mortality in a secondary care hospital intensive care unit. Infect Prev Pract. 2023;5(4):100320. doi: 10.1016/j.infpip.2023.100320
  37. Bor C, Demirag K, Okcu O, Cankayali I, Uyar M. Ventilator-associated pneumonia in critically ill patients with intensive antibiotic usage. Pak J Med Sci. 2015;31(6):1441-1446. doi:10.12669/pjms.316.8038
  38. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001;120(2):555-561. doi:10.1378/chest. 120.2.555
  39. Agarwal R, Gupta D, Ray P, Aggarwal AN, Jindal SK. Epidemiology, risk factors and outcome of nosocomial infections in a Respiratory Intensive Care Unit in North India. J Infect. 2006;53(2):98-105. doi:10.1016/j.jinf. 2005.10.021
  40. Lorente L, Lecuona M, Galván R, Ramos MJ, Mora ML, Sierra A. Periodically changing ventilator circuits is not necessary to prevent ventilator-associated pneumonia when a heat and moisture exchanger is used. Infect Control Hosp Epidemiol. 2004;25(12):1077-1082. doi:10. 1086/502347
  41. Nguile-Makao M, Zahar JR, Français A, et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med. 2010; 36(5):781-789. doi:10.1007/s00134-010-1824-6
  42. Ibn Saied W, Mourvillier B, Cohen Y, et al. A Comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Crit Care Med. 2019;47(3):345-352. doi:10.1097/CCM.0000000000003553
  43. Karakuzu Z, Iscimen R, Akalin H, Kelebek Girgin N, Kahveci F, Sinirtas M. Prognostic risk factors in ventilator-associated pneumonia. Med Sci Monit. 2018;24:1321-1328. doi:10.12659/msm.905919
  44. Tuon FF, Graf ME, Merlini A, et al. Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae. Braz J Infect Dis. 2017;21(1):1-6. doi:10.1016/j.bjid. 2016.09.008
  45. Uguz İ, Karasu D, Yılmaz C, et al. Comparison of patients with ventilator-associated pneumonia developed in two different intensive care units of a tertiary hospital. Med J Western Black Sea. 2022;6:358-367.
  46. Zubair S, Ali H, Raza SF, Warind JA, Beg AE, Bushra R. Assessment of frequency and transience rate for ventilator-associated pneumonia (VAP) in geriatric patients in tertiary care settings of Karachi, Pakistan. J Coll Physicians Surg Pak. 2018;28(7):536-540. doi:10.29271/jcpsp.2018. 07.536
  47. Blot S, Koulenti D, Dimopoulos G, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*. Crit Care Med. 2014;42(3):601-609. doi: 10.1097/01.ccm.0000435665.07446.50
  48. Schetz M, De Jong A, Deane AM, et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019;45(6):757-769. doi:10.1007/s00134-019-05594-1
  49. Ni YN, Luo J, Yu H, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017;21(1):36. doi:10.1186/s13054-017-1615-3
  50. Abhyankar S, Leishear K, Callaghan FM, Demner-Fushman D, McDonald CJ. Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients. Crit Care. 2012;16(6):R235. doi:10.1186/cc11903
  51. King P, Mortensen EM, Bollinger M, et al. Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur Respir J. 2013;41(4):929-934. doi:10.1183/09031936.00185211
  52. Nie W, Zhang Y, Jee SH, Jung KJ, Li B, Xiu Q. Obesity survival paradox in pneumonia: a meta-analysis. BMC Med. 2014;12:61. doi:10.1186/1741-7015-12-61
  53. Bailly S, Galerneau LM, Ruckly S, et al. Impact of obstructive sleep apnea on the obesity paradox in critically ill patients. J Crit Care. 2020;56:120-124. doi:10.1016/j.jcrc.2019.12.016
  54. Nseir S, Le Gouge A, Pouly O, et al. Relationship between obesity and ventilator-associated pneumonia: a post hoc analysis of the NUTRIREA2 trial. Chest. 2021;159(6):2309-2317. doi:10.1016/j.chest.2021.01.081
  55. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med. 2004;32(4):998-1003. doi:10.1097/01.ccm.0000119422.93413.08
  56. Bochicchio GV, Joshi M, Bochicchio K, Nehman S, Tracy JK, Scalea TM. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg. 2006;203(4):533-538. doi:10.1016/j.jamcollsurg. 2006.07.001